PHIO Stock Summary and Trading Ideas (Phio Pharmaceuticals Corp. | NASDAQ:PHIO)

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

What symbol and exchange does Phio Pharmaceuticals Corp. shares trade?

Phio Pharmaceuticals Corp. trades on the NASDAQ stock market under the symbol PHIO.

What is Phio Pharmaceuticals Corp. stock price doing today?

As of August 27, 2026, PHIO stock price declined to $1.18 with 51,712 million shares trading.

What is Phio Pharmaceuticals Corp.'s Beta?

PHIO has a beta of 0.30, meaning it tends to be less sensitive to market movements. PHIO has a correlation of 0.00 to the broad based SPY ETF.

How much is Phio Pharmaceuticals Corp. worth?

PHIO has a market cap of $13.71 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Phio Pharmaceuticals Corp. traded in the last 3 year period?

In the last 3 years, PHIO traded as high as $29.07 and as low as $.81.

What are the top ETFs holding Phio Pharmaceuticals Corp.?

The top ETF exchange traded funds that PHIO belongs to (by Net Assets): VXF.

Is Phio Pharmaceuticals Corp. (PHIO) a good investment?

PHIO has underperformed the market in the last year with a return of -42.2%, while SPY returned +20.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PHIO shares. However, PHIO has outperformed the market in the last 3 month and 2 week periods, returning +9.3% and +9.3%, while SPY returned +2.9% and -0.2%, respectively. This indicates PHIO has been having a stronger performance recently.

What are the support and resistance levels for Phio Pharmaceuticals Corp. (PHIO)?

PHIO support price is $1.15 and resistance is $1.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHIO shares will trade within this expected range on the day.